Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections

Bruce E Silverstein,1 Timothy W Morris,2 Lynne S Gearinger,2 Heleen H DeCory,2 Timothy L Comstock21Shasta Eye Medical Group Inc, Redding, CA, 2Bausch and Lomb Inc, Rochester, NY, USABackground: The purpose of this study was to determine the efficacy of besifloxacin ophthalmic suspension 0.6% when us...

Full description

Saved in:
Bibliographic Details
Main Authors: Silverstein BE, Morris TW, Gearinger LS, DeCory HH, Comstock TL
Format: article
Language:EN
Published: Dove Medical Press 2012
Subjects:
Online Access:https://doaj.org/article/295304b480c54ffb87fae764ca57e379
Tags: Add Tag
No Tags, Be the first to tag this record!